Characteristics of included reviews. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the PRISMA assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Result of the ROBIS assessments. by Huixia Ren (500186)

“…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”

Datasets used in the study. by Rajon Banik (12066099)

“…Upazila Health Complexes and Maternal and Child Welfare Centers had significantly higher readiness compared to District Hospitals in 2017. …”

Pan-cancer analyses of GSRS. by Yu Zhang (12946)

Unsupervised clustering of TCGA-KIRC subjects based on glucocorticoid signaling-related genes. by Yu Zhang (12946)

Flowchart of the study population. by Alejandro Rojas Chaves (20614814)

“…<div><p>Introduction</p><p>Recently, efforts to eliminate malaria have shifted focus from symptomatic cases alone to include asymptomatic carriers, who are now recognized as significant contributors to the disease’s transmission and control. …”

Summary of study participants. by Jesús Poch-Páez (21807825)

“…ACE2 expression was slightly elevated in younger children; however, after correction for multiple comparisons, there was no statistically significant association between ACE2 expression and age, antibody titers, or symptom severity.. …”

Participants’ characteristics. by Jesús Poch-Páez (21807825)

“…ACE2 expression was slightly elevated in younger children; however, after correction for multiple comparisons, there was no statistically significant association between ACE2 expression and age, antibody titers, or symptom severity.. …”

Sources of infection. by Jesús Poch-Páez (21807825)

“…ACE2 expression was slightly elevated in younger children; however, after correction for multiple comparisons, there was no statistically significant association between ACE2 expression and age, antibody titers, or symptom severity.. …”

Dynamics of PIF4 protein accumulation and autoinhibition in response to temperature. by Sreya Das (20531295)

Study data. by Jie Liu (15128)

“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”

Approval by the research ethics committee. by Jie Liu (15128)

“…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …”

Homing analysis of GMSCs. by Leyla Tekin (21492873)

Underlying numerical data for Figs 1–7 and S1-S6. by Sreya Das (20531295)

“…We show that <i>PIF4</i> promoter activity is higher in the <i><i>pif4</i></i> mutant but significantly reduced in <i>PIF4</i> overexpression transgenic lines. …”

Design of the D-trial. by Torsten Schober (20485754)

“…In contrast to expectations, neither PD nor DVP had significant effects on the cannabinoid concentration gradient from upper to lower canopy layers. …”

Estimated mean values for light interception. by Torsten Schober (20485754)

“…In contrast to expectations, neither PD nor DVP had significant effects on the cannabinoid concentration gradient from upper to lower canopy layers. …”

Raw data V-trial. by Torsten Schober (20485754)

“…In contrast to expectations, neither PD nor DVP had significant effects on the cannabinoid concentration gradient from upper to lower canopy layers. …”

Raw data D-trial. by Torsten Schober (20485754)

“…In contrast to expectations, neither PD nor DVP had significant effects on the cannabinoid concentration gradient from upper to lower canopy layers. …”